(Q58068775)

English

Novel Insights into Combating Cancer Chemotherapy Resistance Using a Plasmonic Nanocarrier: Enhancing Drug Sensitiveness and Accumulation Simultaneously with Localized Mild Photothermal Stimulus of Femtosecond Pulsed Laser

No description defined

In more languages

Statements

scholarly article

0 references

Novel Insights into Combating Cancer Chemotherapy Resistance Using a Plasmonic Nanocarrier: Enhancing Drug Sensitiveness and Accumulation Simultaneously with Localized Mild Photothermal Stimulus of Femtosecond Pulsed Laser (English)

0 references

condensed matter physics

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

femtosecond laser

1 reference

based on heuristic

inferred from title

object named as

Liming Wang

1

0 references

author name string

Xiaoying Lin

2

0 references

Jing Wang

3

0 references

Zhijian Hu

4

0 references

Yinglu Ji

5

0 references

Shuai Hou

6

0 references

Yuliang Zhao

7

0 references

Xiaochun Wu

8

0 references

Chunying Chen

9

0 references

language of work or name

0 references

publication date

24 March 2014

0 references

Advanced Functional Materials

0 references

24

0 references

27

0 references

4229-4239

0 references

Mechanisms of cancer drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Multidrug resistance in cancer: role of ATP-dependent transporters

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Targeting multidrug resistance in cancer

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Early and delayed clinical cardiotoxicity of doxorubicin

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Phase I and II agents in cancer therapy: two cisplatin analogues and high-dose cisplatin in hypertonic saline or with thiosulfate protection

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Combating the drug resistance of cisplatin using a platinum prodrug based delivery system.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Biologic basis for combining drugs with radiation

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Nanocarriers as an emerging platform for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Plasmonic photothermal heating of intraperitoneal tumors through the use of an implanted near-infrared source

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Gold nanorods and their plasmonic properties.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

The golden age: gold nanoparticles for biomedicine

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Gold nanorods: their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Gold nanostars as thermoplasmonic nanoparticles for optical heating.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Enhancing the Toxicity of Cancer Chemotherapeutics with Gold Nanorod Hyperthermia

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Heat shock factor-1 knockout induces multidrug resistance gene, MDR1b, and enhances P-glycoprotein (ABCB1)-based drug extrusion in the heart

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

NF-kappaB at the crossroads of life and death

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Focus on molecules: nuclear factor-kappaB.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

p53 and breast cancer, an update

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Ultrasound-Induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Overcoming MDR by ultrasound-induced hyperthermia and P-glycoprotein modulation.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Chemical radiosensitizers for use in radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Heat-inducible in vivo gene therapy of colon carcinoma by human mdr1 promoter-regulated tumor necrosis factor-alpha expression

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Near-infrared light triggers release of Paclitaxel from biodegradable microspheres: photothermal effect and enhanced antitumor activity

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Heat shock factors: integrators of cell stress, development and lifespan.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Cross talk between stimulated NF-kappaB and the tumor suppressor p53.

1 reference

https://api.crossref.org/works/10.1002%2FADFM.201400015

21 January 2018

Identifiers

10.1002/ADFM.201400015

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58068775&oldid=1489187918"